<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lake, Noelle</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Livermore, David</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Emerging Resistance among Gram-Negative Pathogens: State of the Challenge</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">6-7</style></pages><abstract><style  face="normal" font="default" size="100%">In the 1980s, antimicrobial resistance among gram-negative (Gm) pathogens seemed to be under control. Much has since changed, and physicians are now facing unprecedented clinical challenges due to the growing proliferation of multidrug-resistant Gm pathogens. This article describes current epidemiological, mechanistic, and demographic trends that are related to this worldwide epidemic.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>